MPM Oncology Impact Management GP LLC's Net Worth

$0

Estimate Recalculated May 9, 2026 10:52AM EST

Who is MPM Oncology Impact Management GP LLC

MPM Oncology Impact Management GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Werewolf Therapeutics, Inc., iTeos Therapeutics, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Oncorus, Inc., and Cullinan Management, Inc..

SEC CIK

MPM Oncology Impact Management GP LLC's CIK is 0001721035

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iTeos Therapeutics, Inc.

Investor
Updated Apr 13, 2021
ScheduledApr 09
ScheduledApr 07 - Apr 08
Jul 28
Showing 4 results

Werewolf Therapeutics, Inc.

Investor
Updated May 06, 2021
May 04
461.41K
Showing 2 results

Harpoon Therapeutics, Inc.

Investor
Updated Jun 02, 2021
ScheduledMay 28 - Jun 02
ScheduledMay 26 - May 27
ScheduledMay 21 - May 24
ScheduledMay 18 - May 20
ScheduledMay 13 - May 17
ScheduledMay 10 - May 12
ScheduledMay 05
ScheduledApr 30 - May 04
ScheduledApr 27 - Apr 29
ScheduledApr 21
ScheduledApr 16 - Apr 20
ScheduledApr 13 - Apr 15
ScheduledApr 09 - Apr 12
Feb 12
Showing 15 results

Spring Bank Pharmaceuticals, Inc.

Investor
Updated Feb 06, 2018
833.84K
Showing 1 results

TCR2 THERAPEUTICS INC.

Investor
Updated Feb 21, 2019
Feb 19
Showing 2 results

SUNESIS PHARMACEUTICALS INC

Investor
Updated Nov 06, 2017
Nov 02 - Nov 06
3.25M
Showing 2 results

Oncorus, Inc.

Investor
Updated Oct 08, 2020
Oct 06
Showing 2 results

Cullinan Oncology, Inc.

Investor
Updated Aug 25, 2021
ScheduledAug 23 - Aug 25
ScheduledAug 11
Jan 12
Form 3/A
Showing 4 results